Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Roberto Cauda and Antonio Gasbarrini.
Roberto Cauda
Connection Strength
0.380
Antonio Gasbarrini
  1. Off-label use of tocilizumab in patients with SARS-CoV-2 infection. J Med Virol. 2020 10; 92(10):1787-1788.
    View in: PubMed
    Score: 0.222
  2. Sarilumab use in severe SARS-CoV-2 pneumonia. EClinicalMedicine. 2020 Oct; 27:100553.
    View in: PubMed
    Score: 0.057
  3. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive. J Infect. 2021 01; 82(1):159-198.
    View in: PubMed
    Score: 0.055
  4. Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin. Intern Emerg Med. 2017 Oct; 12(7):1059-1067.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.